Amniotic fluid-derived stem cells in regenerative medicine research

Sunyoung Joo, In Kap Ko, Anthony Atala, James J. Yoo, Sang Jin Lee

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The stem cells isolated from amniotic fluid present an exciting possible contribution to the field of regenerative medicine and amniotic fluid-derived stem (AFS) cells have significant potential for research and therapeutic applications. AFS cells are multipotent, showing the ability to differentiate into cell types from all three embryonic germ layers. They express both embryonic and adult stem cell markers, expand extensively without feeder cells, double in 36 h, and are not tumorigenic. The AFS cells can be maintained for over 250 population doublings and preserve their telomere length and a normal karyotype. They differentiate easily into specific cell lineages and do not require human embryo tissue for their isolation, thus avoiding the current controversies associated with the use of human embryonic stem (ES) cells. The discovery of the AFS cells has been recent, and a great deal of work remains to be performed on the characterization and use of these cells. This review describes the various differentiated lineages that AFS cells can form and the future of these promising new stem cells in regenerative medicine research.

Original languageEnglish
Pages (from-to)271-280
Number of pages10
JournalArchives of Pharmacal Research
Volume35
Issue number2
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Fingerprint

Regenerative Medicine
Amniotic Fluid
Stem cells
Stem Cells
Fluids
Research
Multipotent Stem Cells
Therapeutic Human Experimentation
Feeder Cells
Germ Layers
Adult Stem Cells
Telomere
Cell Lineage
Embryonic Stem Cells
Karyotype
Embryonic Structures
Tissue
Population

Keywords

  • Amniotic fluid-derived stem (AFS) cells
  • Differentiation
  • Reconstruction
  • Regeneration
  • Regenerative medicine
  • Tissue engineering

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry

Cite this

Amniotic fluid-derived stem cells in regenerative medicine research. / Joo, Sunyoung; Ko, In Kap; Atala, Anthony; Yoo, James J.; Lee, Sang Jin.

In: Archives of Pharmacal Research, Vol. 35, No. 2, 01.02.2012, p. 271-280.

Research output: Contribution to journalArticle

Joo, Sunyoung ; Ko, In Kap ; Atala, Anthony ; Yoo, James J. ; Lee, Sang Jin. / Amniotic fluid-derived stem cells in regenerative medicine research. In: Archives of Pharmacal Research. 2012 ; Vol. 35, No. 2. pp. 271-280.
@article{ec11d7505b8d4698bd4b0180fe70bcb6,
title = "Amniotic fluid-derived stem cells in regenerative medicine research",
abstract = "The stem cells isolated from amniotic fluid present an exciting possible contribution to the field of regenerative medicine and amniotic fluid-derived stem (AFS) cells have significant potential for research and therapeutic applications. AFS cells are multipotent, showing the ability to differentiate into cell types from all three embryonic germ layers. They express both embryonic and adult stem cell markers, expand extensively without feeder cells, double in 36 h, and are not tumorigenic. The AFS cells can be maintained for over 250 population doublings and preserve their telomere length and a normal karyotype. They differentiate easily into specific cell lineages and do not require human embryo tissue for their isolation, thus avoiding the current controversies associated with the use of human embryonic stem (ES) cells. The discovery of the AFS cells has been recent, and a great deal of work remains to be performed on the characterization and use of these cells. This review describes the various differentiated lineages that AFS cells can form and the future of these promising new stem cells in regenerative medicine research.",
keywords = "Amniotic fluid-derived stem (AFS) cells, Differentiation, Reconstruction, Regeneration, Regenerative medicine, Tissue engineering",
author = "Sunyoung Joo and Ko, {In Kap} and Anthony Atala and Yoo, {James J.} and Lee, {Sang Jin}",
year = "2012",
month = "2",
day = "1",
doi = "10.1007/s12272-012-0207-7",
language = "English",
volume = "35",
pages = "271--280",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "2",

}

TY - JOUR

T1 - Amniotic fluid-derived stem cells in regenerative medicine research

AU - Joo, Sunyoung

AU - Ko, In Kap

AU - Atala, Anthony

AU - Yoo, James J.

AU - Lee, Sang Jin

PY - 2012/2/1

Y1 - 2012/2/1

N2 - The stem cells isolated from amniotic fluid present an exciting possible contribution to the field of regenerative medicine and amniotic fluid-derived stem (AFS) cells have significant potential for research and therapeutic applications. AFS cells are multipotent, showing the ability to differentiate into cell types from all three embryonic germ layers. They express both embryonic and adult stem cell markers, expand extensively without feeder cells, double in 36 h, and are not tumorigenic. The AFS cells can be maintained for over 250 population doublings and preserve their telomere length and a normal karyotype. They differentiate easily into specific cell lineages and do not require human embryo tissue for their isolation, thus avoiding the current controversies associated with the use of human embryonic stem (ES) cells. The discovery of the AFS cells has been recent, and a great deal of work remains to be performed on the characterization and use of these cells. This review describes the various differentiated lineages that AFS cells can form and the future of these promising new stem cells in regenerative medicine research.

AB - The stem cells isolated from amniotic fluid present an exciting possible contribution to the field of regenerative medicine and amniotic fluid-derived stem (AFS) cells have significant potential for research and therapeutic applications. AFS cells are multipotent, showing the ability to differentiate into cell types from all three embryonic germ layers. They express both embryonic and adult stem cell markers, expand extensively without feeder cells, double in 36 h, and are not tumorigenic. The AFS cells can be maintained for over 250 population doublings and preserve their telomere length and a normal karyotype. They differentiate easily into specific cell lineages and do not require human embryo tissue for their isolation, thus avoiding the current controversies associated with the use of human embryonic stem (ES) cells. The discovery of the AFS cells has been recent, and a great deal of work remains to be performed on the characterization and use of these cells. This review describes the various differentiated lineages that AFS cells can form and the future of these promising new stem cells in regenerative medicine research.

KW - Amniotic fluid-derived stem (AFS) cells

KW - Differentiation

KW - Reconstruction

KW - Regeneration

KW - Regenerative medicine

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84862701575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862701575&partnerID=8YFLogxK

U2 - 10.1007/s12272-012-0207-7

DO - 10.1007/s12272-012-0207-7

M3 - Article

C2 - 22370781

AN - SCOPUS:84862701575

VL - 35

SP - 271

EP - 280

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 2

ER -